Regulated information

Monthly information regarding the total number of voting rights – February 2025

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
 

Buyback programs - February 2025

Monthly communication regarding buyback programs 

Buyback programs - January 2025

Monthly communication regarding buyback programs 

Monthly information regarding the total number of voting rights – January 2025

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
 

Annual sales 2024: €539 million

Annual sales: €539 million (up 2.2% at constant exchange rates and up 1.9%. on a reported basis)
Annual sales of Essential products: €328 million (up 4.6% at constant exchange rates and on a reported basis)

2025 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2025.

Monthly information regarding the total number of voting rights – December 2024

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
 

Buyback programs - December 2024

Monthly communication regarding buyback programs 

Vétoquinol markets CEFTIOCYL® and KEFLORIL® two new injectable antibiotics for livestock

Lure, December 15, 2010 – In line with recent announcements, Vétoquinol is
launching Ceftiocyl® and Kefloril®, two new injectable antibiotics for livestock.
The products are being brought to market by the Group and its subsidiaries in
both domestic and export markets.

Monthly information regarding the total number of voting rights and shares making of the share capital - November 2010

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »